In the past two years, over two million adverse event reports were submitted to the FDA by patients and healthcare providers. Each year, over 770,000 people are injured or die from adverse drug events. Chatbots are an increasingly popular tool for pharmaceutical brand marketing and patient support, but few are equipped to accurately flag if a patient is having a medication-induced side effect, which can hinder pharmacovigilance processes and success.

Orbita’s new platform-agnostic adverse event detection module integrates into existing chat services to accurately detect and seamlessly assist users in reporting adverse reactions to medications, ultimately improving the efficiency and timeliness of adverse event reporting.